A study found that less than 1 in 1,000 adolescents received gender-affirming medication from 2018 to 2022. Out of over 5 million patients surveyed, 926 received puberty blockers and 1,927 hormones. The study’s release comes amid debates over gender-affirming care laws for minors, with at least 26 states restricting such care. The researchers argue that gender-affirming care isn’t used as much as believed and is essential for psychological functioning.
Massachusetts health firm reaches $80,000 settlement with HHS following ransomware investigation
The U.S. Department of Health and Human Services (HHS) has fined Elgon Information Systems $80,000 following a ransomware attack in 2023 that saw over 31,000
